slides · global inventory
Market Segmentation Pyramid
Tool collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 975
Current window 661-690
Pages 33
Rows per page 30
Tool
661-690 of 975
24
The slide uses a 2x2 grid of metrics to frame the problem/opportunity.BioAtla | Investor Presentation Deck | 55 slides · BioAtla
Pitch deck Investor relations Beat · Market Sizing1 hit
29
The slide uses a grid of metrics to define the addressable market and the clinical problem (progression after 1L).BioAtla | Investor Presentation Deck | 55 slides · BioAtla
Pitch deck Investor relations Beat · Market Sizing1 hit
04
Coupang | Results Presentation Deck | 28 slidesCoupang | Results Presentation Deck | 28 slides · Coupang
Conference presentation Investor relations Beat · Problem1 hit
10
The slide uses a bar chart to show potential growth (2-3x) and donut charts to show user penetration segments.Deliveroo | Investor Event Presentation Deck | 112 slides · Deliveroo
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
33
The chart is a conceptual representation of market size, explicitly marked 'Not to Scale'.Deliveroo | Investor Event Presentation Deck | 112 slides · Deliveroo
Conference presentation Investor relations Beat · Satisfaction1 hit
18
The slide uses a structured comparison of four distinct disease areas to justify the market potential of the EQ101 franchise.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations Beat · Market Size1 hit
13
Includes a biological diagram illustrating the RAS protein state transition and mutation impact.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
05
The table uses a heatmap-style color coding where red indicates existing targeted therapy markets and teal indicates blue ocean opportunities.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Introduction to Erasca and RAS/MAPK pathwayLoop · Logic Chain1 hit
36
The diagram shows the EGFR signaling pathway and the inhibitory effect of ERAS-801.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Erasca's pipeline and clinical data1 hit
20
The slide uses a combination of tables and a central callout to illustrate TAM vs SAM.FGI Industries | Investor Presentation Deck | 30 slides · FGI Industries
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
08
Uses a visual growth projection (circles) to represent market expansion.FinWise Bancorp | Investor Presentation Deck | 24 slides · FinWise Bancorp
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit
17
Uses a funnel visualization to represent TAM, SAM, and SOM-like segments.Hagerty | Investor Presentation Deck | 24 slides · Hagerty
Pitch deck Investor relations 1 hit
07
Uses a bubble-style comparison to visualize market scale.HeartBeam | Results Presentation Deck | 19 slides · HeartBeam
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
13
The chart uses a concentric semi-circle design to represent market layers, with a specific focus on HD trucking as the core.Hyzon | Investor Conference Presentation Deck | 20 slides · Hyzon
Conference presentation Investor relations Beat · Rising Success1 hit
55
The slide uses a bar chart comparison to highlight the efficacy gap between established treatments and placebo.Immix Biopharma | Investor Presentation Deck | 60 slides · Immix Biopharma
Pitch deck Investor relations Loop · Golden Circle1 hit
19
The slide uses a bottom-up summation approach to define the total eligible patient pool.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & Proof1 hit
57
The slide compares efficacy benchmarks of established competitors (AbbVie, J&J, Takeda) to set a baseline for the IMX-120 opportunity.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
31
Includes a comparative table of clinical outcomes (ORR/CR/sCR) for NXC-201 vs. competitors.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Evidence & ProofLoop · Quick Win Big Bet1 hit
09
Includes a mechanism of action diagram, a market data table, and a comparison of current therapy limitations.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 1 hit
10
LMM stands for Lower Middle Market.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Beat · Market Size1 hit
18
The slide uses a combination of a horizontal bar chart and tabular data represented by circles to show market penetration and investment.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Pitch deck Investor relations Beat · Market SizeLoop · Why Now1 hit
09
The slide uses a structured table to contrast two distinct patient populations (ALK+ vs ROS1+) across three lines of therapy (1L, 2L, 3L+).Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
The table highlights the clinical gap in patients with prior kinase inhibitor treatment, specifically those with G2032R mutations.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Market SizingLoop · Cost Of Inaction1 hit
21
The slide uses a structured table to segment market opportunity by biological markers.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
21
The table segments indications by Squamous cell prevalence and NF2 mutation prevalence.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Voice Of Customer1 hit
46
The chart uses a pie slice representation to show market segments against a total GDP of $23.3T.SoftBank | Results Presentation Deck | 71 slides · SoftBank
Conference presentation Investor relations 1 hit
47
The pie chart shows Logistics at 9% ($0.4T) and Ads at 1% ($0.1T) of a $5.0T total.SoftBank | Results Presentation Deck | 71 slides · SoftBank
Conference presentation Investor relations 1 hit
26
The slide uses a table format to compare market segments.SoftBank | Results Presentation Deck | 72 slides · SoftBank
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
17
Uses a concentric circle diagram to show market segments from total global audio to premium home audio, with a callout for current revenue.Sonos | Investor Presentation Deck | 21 slides · Sonos
Pitch deck Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
29
Uses a nested circle diagram to show market segmentation and penetration.Sonos | Results Presentation Deck | 40 slides · Sonos
Conference presentation Investor relations Beat · Long-term Growth and Outlook1 hit